The Group's trading performance for the first quarter is in line with the Board's expectations, with both Healthcare and Industrial performing as anticipated.
Scapa is well positioned to make further progress this year and the Board remains confident about the Group's outlook.
Statement regarding possible offer for Anglo American
Persimmon – Q1 Trading Statement
London Stock Exchange Group plc: Q1 2024 Trading Update
Unilever Trading Statement – First Quarter 2024
J Sainsbury Plc Preliminary Results
AstraZeneca Plc – Q1 2024 results
Delivered to your inbox every Friday